A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state

European Journal of Cancer Prevention

Volumn 20, Issue 3, 2011, Pages 248-251

  Katafigiotis, Sokratis ^a   Papamichos, Spyros I ^a   Katopodi, Roula ^a   Papazisis, Konstantinos ^c   Mylonaki, Efi ^b   Repana, Dimitra ^c   Kotoula, Vassiliki ^a   Karavidopoulou, Youla ^a   Agorastos, Theodoros ^a   Tarlatzis, Basil C ^a   Lambropoulos, Alexandros F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

cancer; OCT4; OCT4B; POU5F1 polymorphism; rs3130932

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOGENESIS; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OCT4 GENE; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON, INITIATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 79955072963     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834474c7     Document Type: Article

References (15)

1. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells 26:3068-3074.
2. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956. (Pubitemid 41345211)
3. De Jong J, Looijenga L (2006). Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 12:171-203. (Pubitemid 46524130)
4. Kotoula V, Papamichos SI, Lambropoulos AF (2008). Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 26:290-291.
5. Lee J, Kim HK, Rho JY, Han YM, Kim J (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 281:33554-33565. (Pubitemid 46036736)
6. Liedtke S, Stephan M, Kögler G (2008). Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 389:845-850.
7. Monk M, Holding C (2001). Human embryonic genes re-expressed in cancer cells. Oncogene 20:8085-8091. (Pubitemid 34028332)
8. Papamichos SI, Kotoula V, Tarlatzis BC, Agorastos T, Papazisis K, Lambropoulos AF (2009a). OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness. Mol Hum Reprod 15:269-270.
9. Papamichos SI, Lambropoulos AF, Kotoula V (2009b). OCT4B expression in PBMNCs suggests the existence of an alternative OCT4 promoter. Genes Chromosomes Cancer 48:1112-1114.
10. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature 414:105-111. (Pubitemid 33041634)
11. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26:495-502. (Pubitemid 40246573)
12. Takeda J, Seino S, Bell GI (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20:4613-4620.
13. Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755-768.
14. Wang X, Zhao Y, Xiao Z, Chen B, Wei Z, Wang B, et al. (2009). Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells 27:1265-1275.
15. Wicha MS, Liu S, Dontu G (2006). Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66:1883-1890. 1895-1906.